Financials
Financial year 2025
RESEARCH, DEVELOPMENT AND SALES FOR MEDECINE from Hasselt, company number BE0453323857, closed financial year 2025 with a result of € 278,261 after tax. For that financial year RESEARCH, DEVELOPMENT AND SALES FOR MEDECINE recorded a gross margin of € 375,984 and equity of € 771,485. Compared with financial year 2024, the result moved from € 199,171 to € 278,261. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.
€ 771,485
▲ 56% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 278,261
▲ 40% vs 2024
Profit after tax over the fiscal year.
€ 597,381
▲ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 561,038.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 3,465
▼ 70% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 19,463
▲ 12% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 35,867
▲ 20% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 245,374 | € 225,701 | € 271,466 | € 375,984 | ▲ 39% |
| Profit after taxes | € 175,074 | € 165,000 | € 199,171 | € 278,261 | ▲ 40% |
| Equity | € 429,053 | € 594,053 | € 493,224 | € 771,485 | ▲ 56% |
| Total debts | € 158,211 | € 77,090 | € 397,264 | € 85,114 | ▼ 79% |
| Cash | € 434,771 | € 137,279 | € 470,136 | € 597,381 | ▲ 27% |
| Retained profit | € 218,606 | € 383,606 | € 282,777 | € 561,038 | ▲ 98% |
| Dividend | € 0 | € 0 | € 300,000 | € 0 | ▼ 100% |
| Bank debt | € 101,408 | € 212 | € 15 | € 0 | ▼ 100% |
| Balance sheet total | € 587,264 | € 671,143 | € 890,488 | € 856,599 | ▼ 4% |
By gross margin, RESEARCH, DEVELOPMENT AND SALES FOR MEDECINE ranks 3rd of 7 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Hasselt that publish figures (fiscal year 2025).
Key figures of RESEARCH, DEVELOPMENT AND SALES FOR MEDECINE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about RESEARCH, DEVELOPMENT AND SALES FOR MEDECINE the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to RESEARCH, DEVELOPMENT AND SALES FOR MEDECINE?
What happened at RESEARCH, DEVELOPMENT AND SALES FOR MEDECINE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Maria Berghs stepped down as director. NBB
- Peter Reyskens stepped down as director. NBB
- Freddy Reyskens stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 278,261 (▲ 40% vs 2024). Source: NBB ↗
- Peter Reyskens became a director. NBB
- Maria Berghs became a director. NBB
- New establishment in Hasselt. KBO
- Freddy Reyskens became a director. NBB
In short
From € 175,074 profit in 2022 to € 278,261 profit in 2025.
Paid € 277,112 in corporate taxes since 2022.
Best year ever: 2025, with € 278,261 profit.
Paid out € 300,000 in dividends to the owners in total.
Management
The shares are held by RESCOM (100%).
Directors
According to the 2025 annual accounts
Maria Berghs
Director
since 2000 · until 2027
since 2004 · until 2027
Freddy Reyskens
Managing director
since 1994 · until 2027
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Gaarveldstraat 83
3500 Hasselt
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Hasselt
Same main activity (Groothandel in farmaceutische en medische artikelen), 6 active companies in Hasselt, largest first.
€ 2.1 million gross margin · 2025
€ 412,758 gross margin · 2025
€ 102,988 gross margin · 2025
€ 79,665 gross margin · 2025
€ 59,645 gross margin · 2025
€ 48,454 gross margin · 2025
Details
- Company number
- 0453.323.857
- VAT number
- BE 0453.323.857
- Registered office
- Gaarveldstraat 83, 3500 Hasselt
- Names & denominations
- RESEARCH, DEVELOPMENT AND SALES FOR MEDECINE · R.D.S.M.
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 29 August 1994
- Peppol
- Active · Active since 2 Dec 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten